Isoflurane prevents platelets from enhancing neutrophil-induced coronary endothelial dysfunction

Anesthesia and Analgesia

Volumn 101, Issue 5, 2005, Pages 1261-1268

  Hu, Guochang ^a,b   Salem, M Ramez ^a,b   Crystal, George J ^a,b  

^a ADVOCATE ILLINOIS MASONIC MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; CELL ADHESION MOLECULE; FLUORESCENT DYE; ISOFLURANE; NITROPRUSSIDE SODIUM; PENTOBARBITAL; SUPEROXIDE; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL EXPERIMENT; ARTICLE; CELL ADHESION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; DOG; ENDOTHELIUM LESION; HEART PROTECTION; MINIMUM LUNG ALVEOLUS CONCENTRATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SPECTROPHOTOMETRY; THROMBOCYTE; VASODILATATION;

EID: 27444444592     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000181340.28271.4F     Document Type: Article

References (35)

1. Li N, Hu H, Lindqvist M, et al. Platelet-leukocyte cross talk in whole blood. Arterioscler Thromb Vasc Biol 2000;20:2702-8.
2. Dore M. Platelet-leukocyte interactions. Am Heart J 1998;135: S146-51.
3. Siminiak T, Flores NA, Sheridan DJ. Neutrophil interactions with endothelium and platelets: possible role in the development of cardiovascular injury. Eur Heart J 1995;16:160-70.
4. Kogaki S, Sawa Y, Matsushita T, et al. Selectin on activated platelets enhances neutrophil endothelial adherence in myocardial reperfusion injury. Cardiovasc Res 1999;43:968-73.
5. 2 generation at high concentrations. J Leukoc Biol 1991;49:83-9.
6. Lefer AM, Campbell B, Scalia R, Lefer DJ. Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion: role of selections. Circulation 1998;98:1322-8.
7. Merhi Y, Provost P, Guidoin R, Latour J-G. Importance of platelets in neutrophil adhesion and vasoconstriction after deep carotid arterial injury by angioplasty in pigs. Arterioscler Thromb 1997;17:1185-91.
8. Tanaka K, Ludwig LM, Kersten JR, et al. Mechanisms of cardioprotection by volatile anesthetics. Anesthesiology 2004;100:707-21.
9. Hu G, Vasiliauskas T, Salem MR, et al. Neutrophils pretreated with volatile anesthetics lose ability to cause cardiac dysfunction. Anesthesiology 2003;98:712-8.
10. Hu G, Salem MR, Crystal GJ. Isoflurane and sevoflurane precondition against neutrophil-induced contractile dysfunction in isolated rat hearts. Anesthesiology 2004;100:489-97.
11. Hu G, Vinten-Johansen J, Salem MR, et al. Isoflurane inhibits neutrophil-endothelium interactions in the coronary circulation: lack of role for adenosine triphosphate-sensitive potassium channels. Anesth Analg 2002;94:849-56.
12. Mobert J, Zahler S, Becker BF, Conzen PF. Inhibition of neutrophil activation by volatile anesthetics decreases adhesion to cultured human endothelial cells. Anesthesiology 1999;90:1372-81.
13. de Klaver MJ, Manning L, Palmer LA, Rich GF. Isoflurane pretreatment inhibits cytokine-induced cell death in cultured rat smooth muscle cells and human endothelial cells. Anesthesiology 2002;97:24-32.
14. 2 formation, possibly by suppression of cyclooxygenase activity. Anesthesiology 1996;85:1447-53.
15. 2 receptor. Anesth Analg 1995;81:114-8.
16. Kohro S, Yamakage M. Direct inhibitory mechanisms of halothane on human platelet aggregation. Anesthesiology 1996;85:96-106.
17. 2 signaling. Anesthesiology 1998;88:440-51.
18. Blaise GA, Parent M, Laurin S, et al. Platelet-induced vasomotion of isolated canine coronary artery in the presence of halothane or isoflurane. J Cardiothorac Vasc Anesth 1994;8:175-81.
19. Heindl B, Becker BF, Zahler S, Conzen PF. Volatile anaesthetics reduce adhesion of blood platelets under low-flow conditions in the coronary system of isolated guinea pig hearts. Acta Anaesthesiol Scand 1998;42:995-1003.
20. Fauss BG, Meadows JC, Bruni CY, Qureshi GD. The in vitro and in vivo effects of isoflurane and nitrous oxide on platelet aggregation. Anesth Analg 1986;65:1170-4.
21. de Rossi LW, Horn NA, Hecker KE, et al. Effect of halothane and isoflurane on binding of ADP- and TRAP-6-activated platelets to leukocytes in whole blood. Anesthesiology 2002;96:117-24.
22. Horn NA, de Rossi L, Robitzsch T, et al. The effects of sevoflurane and desflurane in vitro platelet-leukocyte adhesion in whole blood. Anaesthesia 2003;58:312-9.
23. Fröhlich D, Rothe G, Schmitz G, Hansen E. Volatile anaesthetics induced in the expression of P-selectin and glycoprotein 1b on the surface of platelets in vitro. Eur J Anaesthesiol 1998;15:641-8.
24. Pearson PJ, Schaff HV, Vanhoutte PM. Acute impairment of endothelium-dependent relaxations to aggregating platelets following reperfusion injury in canine coronary arteries. Circ Res 1990;67:385-93.
25. Kiechenbaum LA, Aziz M, Astiz ME, et al. Influence of rheologic changes and platelet-neutrophil interactions on cell filtration in sepsis. Am J Resp Crit Care Med 2000;161:1602-7.
26. Koblin DD, Eger EI II, Johnson BH, et al. Minimum alveolar concentrations and oil/gas partition coefficients of four anesthetic isomers. Anesthesiology 1981;54:314-7.
27. Lerman J, Willis MM, Gregory GA, Eger EI II. Osmolarity determines the solubility of anesthetics in aqueous solutions at 37°C. Anesthesiology 1983;59:554-8.
28. Zar JH. Biostatistical analysis. Englewood Cliffs, NJ: Prentice-Hall, 1974.
29. Merhi Y, Provost P, Chauvet P, et al. Selectin blockade reduces neutrophil interaction with platelets at the site of deep arterial injury by angioplasty in pigs. Arteriocler Throm Vasc Biol 1999;19:372-7.
30. Gawaz M. Role of platelets in coronary thrombosis and reperfusion in ischemic myocardium. Cardiovasc Res 2004;61:498-511.
31. Seno T, Inoue N, Gao D, et al. Involvement of NADH/NADPH oxidase in human platelet ROS production. Thrombosis Res 2001;103:399-409.
32. 2-receptor activation inhibits neutrophil-mediated injury to coronary endothelium. Am J Physiol 1996;27:H1456-64.
33. Fan H, Sun B, Gu Q, et al. Oxygen radicals trigger activation of NF-κ B and AP-1 and upregulation of ICAM-1 in reperfused canine heart. Am J Physiol 2002;282:H1778-86.
34. Montrucchio G, Alloatti G, Camussi G. Role of platelet-activating factor in cardiovascular pathophysiology. Physiol Rev 2000;80:1669-99.
35. 2) with vasoconstrictors on diameter of large coronary arteries of the dog. J Cardiovasc Pharmacol 1984;6:20-7.